Gong, Taiqian
34  results:
?
1

TESC acts as a prognostic factor and promotes epithelial-me..:

Dong, Yanxin ; Fan, Boshi ; Li, Mingyang...
Pathology - Research and Practice.  253 (2024)  - p. 154964 , 2024
 
?
 
?
4

Identification and experimental verification of an anoikis ..:

Zhang, Jia-Le ; Dong, Yan-Xin ; Di, Shou-Yin..
Translational Cancer Research.  12 (2023)  4 - p. 887-903 , 2023
 
?
5

Tumor associated macrophages in esophageal squamous carcino..:

Zhang, Jiale ; Dong, Yanxin ; Di, Shouyin...
Biomedicine & Pharmacotherapy.  167 (2023)  - p. 115610 , 2023
 
?
 
?
7

FAM107A as a tumor suppressor in esophageal squamous carcin..:

Zhang, Jiale ; Di, Shouyin ; Li, Mingyang...
Pathology - Research and Practice.  252 (2023)  - p. 154945 , 2023
 
?
9

ASO Author Reflections: 3-Year Survival Outcomes of Lymphad..:

Fan, Boshi ; Gong, Taiqian
Annals of Surgical Oncology.  30 (2023)  11 - p. 6737-6738 , 2023
 
?
10

Three-Field Versus Two-Field Lymphadenectomy in Minimally I..:

Fan, Boshi ; Sun, Zengfeng ; Lu, Jing...
Annals of Surgical Oncology.  30 (2023)  11 - p. 6730-6736 , 2023
 
?
12

196. RISK FACTORS OF CERVICAL LYMPH NODE METASTASIS IN ESCC..:

Gong, Taiqian
Diseases of the Esophagus.  35 (2022)  Supplement_2 - p. , 2022
 
?
13

Short-term outcomes of neoadjuvant sintilimab with chemothe..:

Fan, Bo-Shi ; Wang, Xing-Tong ; Di, Shou-Yin...
Translational Cancer Research.  11 (2022)  6 - p. 1697-1704 , 2022
 
?
14

513. RISK FACTORS OF CERVICAL LYMPH NODE METASTASIS IN ESOP..:

Gong, Taiqian
Diseases of the Esophagus.  35 (2022)  Supplement_2 - p. , 2022
 
?
15

520. EFFICACY AND SAFETY OF NEOADJUVANT CHEMOTHERAPY AND IM..:

Gong, Taiqian ; Gong, Taiqian ; Song, Weian...
Diseases of the Esophagus.  35 (2022)  Supplement_2 - p. , 2022
 
1-15